Effect of Albumin on size of hematoma in Hemorrhagic Stroke
Phase 2
- Conditions
- Hemorrhagic Stroke.Intracerebral Haemorrhage, Unspecified
- Registration Number
- IRCT201201018574N1
- Lead Sponsor
- Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria : Primary Hemorrhagic Stroke; 24 hours from symptom onset; Above 18 years old.
Exclusion Criteria : Hematoma volume less than 7 ml; Need surgical evacuation; Pregnancy; Lactation; Systolic blood pressure less than 100 mmHg or more than 250 mmHg; Anticoagulant or Thrombolytic therapy; Serum Creatinine more than 2 mg/dl; History of known allergy to Albumin; History of severe allergic reactions known as latex gloves; Exacerbation of congestive heart failure within the past 6 months; Acute myocardial infarction in the last 6 months.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The hematoma volume. Timepoint: Befor intervention, The end of intervention (One week). Method of measurement: The hematoma volume on CT scan (ml) : Length of maximum appearance of hematoma (cm) × Width of same cut (cm) × Number of cuts including bleeding / 2.
- Secondary Outcome Measures
Name Time Method eurological deficits. Timepoint: Befor intervention, After one month. Method of measurement: NIHSS criteria.